Research ArticleArticle
The JAK1/2 inhibitor ruxolitinib reverses interleukin-6-mediated suppression of drug detoxifying proteins in cultured human hepatocytes
Marie Febvre-James, Arnaud Bruyere, Marc Le Vee and Olivier Fardel
Drug Metabolism and Disposition November 21, 2017, dmd.117.078048; DOI: https://doi.org/10.1124/dmd.117.078048
Marie Febvre-James
IRSET/INSERM U1085, University of Rennes 1
Arnaud Bruyere
IRSET/INSERM U1085, University of Rennes 1
Marc Le Vee
IRSET/INSERM U1085, University of Rennes 1
Olivier Fardel
IRSET/INSERM U1085, University of Rennes 1
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
The JAK1/2 inhibitor ruxolitinib reverses interleukin-6-mediated suppression of drug detoxifying proteins in cultured human hepatocytes
Marie Febvre-James, Arnaud Bruyere, Marc Le Vee and Olivier Fardel
Drug Metabolism and Disposition November 21, 2017, dmd.117.078048; DOI: https://doi.org/10.1124/dmd.117.078048
Research ArticleArticle
The JAK1/2 inhibitor ruxolitinib reverses interleukin-6-mediated suppression of drug detoxifying proteins in cultured human hepatocytes
Marie Febvre-James, Arnaud Bruyere, Marc Le Vee and Olivier Fardel
Drug Metabolism and Disposition November 21, 2017, dmd.117.078048; DOI: https://doi.org/10.1124/dmd.117.078048
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement